Moreover, the observed decrease in MK values in patients with AD aligns with the known pathological features of AD, including neuronal loss, synaptic degeneration, and accumulation of amyloid‐β plaques and tau tangles (DeTure and Dickson 2019; Falcon et al. This evidence concerns the gene MAPT and Alzheimer disease.